The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 2-9A MM: Global clinical trials

Sat. Oct 13, 2018 9:00 AM - 10:00 AM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Hiroshi Handa (Gunma University Graduate School of　Medicine Department of Hematology, Japan)

【Ｅ】

[OS2-9A-3] Phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in AL amyloidosis patients

Camille V. Edwards1, Divaya Bhutani2, Markus Mapara2, Jai Radhakrishnan3, Sofia Shames4, Mathew S. Maurer4, Siyang Leng2, Alan Solomon5, Suzanne Lentzsch2, Andrew Eisenberger2 (1.Department of Hematology and Oncology, Boston Medical Center, Boston, United States of America, 2.Division of Hematology and Oncology, Columbia University Medical Center, New York, United States of America, 3.Division of Nephrology, Columbia University Medical Center, New York, United States of America, 4.Division of Cardiology, Columbia University Medical Center, New York, United States of America, 5.Graduate School of Medicine, University of Tennessee, Knoxville, United States of America)

Abstract password authentication.
Password is written on a program and abstract book.

Password